In a regulatory filing, Iovance (IOVA) told its investors that it does not hold cash deposits or securities at Silicon Valley Bank (SIVB), and has no exposure to or business relationship with Silicon Valley Bank.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on IOVA:
- Iovance Biotherapeutics to Present at Upcoming Conferences
- Iovance Biotherapeutics price target lowered to $15 from $25 at Oppenheimer
- Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates
- Iovance Biotherapeutics reports Q4 EPS (64c), consensus (64c)
- Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, February 28, 2023
